论文部分内容阅读
慢性活动性肝炎(简称慢活肝)主要是由乙型肝炎病毒引起。从病因的角度来看,抗病毒治疗是治疗的中心环节.现将慢活肝的治疗介绍如下: 一、治疗现状与前景 目前用于治疗慢活肝的药物种类繁多,至今国内外在治疗效果上仍无重大突破。几年来国内学者在慢活肝的治疗上做了大量工作。统计1985年的三次全国性肝炎会议上发表的治疗肝炎药物共70多种,其中以保护肝细胞,恢复肝功能的药物为最多。其次为抗病毒药物。过去由于对病例的选择、
Chronic active hepatitis (referred to as slow living liver) is mainly caused by the hepatitis B virus. From the etiology point of view, antiviral therapy is the central part of the treatment. Now slow liver treatment is described as follows: First, the treatment of the status quo and prospects Currently used for the treatment of slow-living liver a wide range of drugs, so far at home and abroad in the treatment effect There is still no major breakthrough. Over the past few years, domestic scholars have done a lot of work on the treatment of chronic liver disease. Statistics of 1985, three national hepatitis meeting published a total of more than 70 kinds of treatment of hepatitis drugs, including the protection of liver cells, the largest number of drugs to restore liver function. Followed by antiviral drugs. In the past due to the choice of cases,